- Home
- MEDP vs GTLB Comparison
MEDP vs GTLB Comparison
Compare MEDP & GTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- GTLB
- Stock Information
- Founded
- MEDP 1992
- GTLB 2011
- Country
- MEDP United States
- GTLB United States
- Employees
- MEDP N/A
- GTLB N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- GTLB EDP Services
- Sector
- MEDP Health Care
- GTLB Technology
- Exchange
- MEDP Nasdaq
- GTLB Nasdaq
- Market Cap
- MEDP 11.7B
- GTLB 10.6B
- IPO Year
- MEDP 2016
- GTLB 2021
- Fundamental
- Price
- MEDP $331.00
- GTLB $57.24
- Analyst Decision
- MEDP Buy
- GTLB Strong Buy
- Analyst Count
- MEDP 10
- GTLB 26
- Target Price
- MEDP $389.00
- GTLB $75.88
- AVG Volume (30 Days)
- MEDP 267.5K
- GTLB 3.7M
- Earning Date
- MEDP 02-10-2025
- GTLB 12-05-2024
- Dividend Yield
- MEDP N/A
- GTLB N/A
- EPS Growth
- MEDP 33.84
- GTLB N/A
- EPS
- MEDP 11.42
- GTLB N/A
- Revenue
- MEDP $2,070,866,000.00
- GTLB $711,597,000.00
- Revenue This Year
- MEDP $14.01
- GTLB $30.87
- Revenue Next Year
- MEDP $5.86
- GTLB $24.41
- P/E Ratio
- MEDP $28.98
- GTLB N/A
- Revenue Growth
- MEDP 16.24
- GTLB 32.01
- 52 Week Low
- MEDP $277.72
- GTLB $40.72
- 52 Week High
- MEDP $459.77
- GTLB $78.53
- Technical
- Relative Strength Index (RSI)
- MEDP 43.26
- GTLB 37.74
- Support Level
- MEDP $340.06
- GTLB $57.87
- Resistance Level
- MEDP $359.49
- GTLB $61.32
- Average True Range (ATR)
- MEDP 10.16
- GTLB 3.01
- MACD
- MEDP -0.41
- GTLB -1.14
- Stochastic Oscillator
- MEDP 4.04
- GTLB 5.47
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.